Evaluation of FASN inhibitor & GLP-1 Combination in Preclinical NASH Model

Time: 12:30 pm
day: Day 1 Seminar A Pre-Lunch Tracks

Details:

  • Evaluating the fatty acid synthase (FASN) inhibitor and GLP-1 combination
  • Assessing the anti-fibrotic efficacy by AI digital pathology
  • Understanding MOAs of combination by transcriptomics 

Speakers: